Document is current
Any future updates will be listed below
-
Authors
Golebiewska, Anna
Hau, Ann-Christin
Oudin, Anaïs
Stieber, Daniel
Yabo, Yahaya A.
Baus, Virginie
Barthelemy, Vanessa
Klein, Eliane
Bougnaud, Sébastien
Keunen, Olivier
Wantz, May
Michelucci, Alessandro
Neirinckx, Virginie
Muller, Arnaud
Kaoma, Tony
Nazarov, Petr V.
Azuaje, Francisco
De Falco, Alfonso
Flies, Ben
Richart, Lorraine
Poovathingal, Suresh
Arns, Thais
Grzyb, Kamil
Mock, Andreas
Herold-Mende, Christel
Steino, Anne
Brown, Dennis
May, Patrick
Miletic, Hrvoje
Malta, Tathiane M.
Noushmehr, Houtan
Kwon, Yong-Jun
Jahn, Winnie
Klink, Barbara
Tanner, Georgette
Stead, Lucy F.
Mittelbronn, Michel
Skupin, Alexander
Hertel, Frank
Bjerkvig, Rolf
Niclou, Simone P. http://orcid.org/0000-0002-3417-9534
-
Funding
Funding for this research was provided by:
Télévie-FNRS (n°7.4615.18, n°7.4632.17)
H2020 Marie Skłodowska-Curie Actions (766069)
Fondation Cancer Luxembourg (Pan-RTK)
Fonds National de la Recherche Luxembourg (PEARL award - P16/BM/11192868, C17/BM/11664971)
- License Information
-
More Information
Article History
Received: 30 July 2020
Revised: 11 September 2020
Accepted: 12 September 2020
First Online: 3 October 2020
Compliance with ethical standards
:
: D Brown is CSO at Delmar Pharmaceuticals, A. Steino was preclinical study manager at Delmar Pharmaceuticals. A Golebiewska and S.P. Niclou received a research grant from Delmar Pharmaceuticals. No potential conflict of interest was disclosed by other authors.
